JONATHAN WINDHAM: Open Payments
NPI 1700272127 · PELL CITY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$568 in 27 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $568
Food & beverage: $568
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $97 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $97 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $69 |
| Novo Nordisk Inc | 3 | $61 |
| GlaxoSmithKline, LLC. | 2 | $50 |
| Atland Pharmaceuticals, LLC | 1 | $36 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Insulet Corporation | 1 | $22 |
| Paratek Pharmaceuticals, Inc. | 1 | $22 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: NURTEC ODT, Kerendia, CAPLYTA, TRELEGY ELLIPTA, Wegovy, ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE, REXULTI, Omnipod.
Industry payments across AL — which companies pay providers there.
